Atteggiamento terapeutico nelle anemie

Translated title of the contribution: Therapeutic approach to anemia

A. Iurlo, W. Barcellini, F. Barraco, A. Zanella

Research output: Contribution to journalArticle

Abstract

The therapeutic approach in the most common types of anemia is briefly reviewed. Therapy of sideropenic anemia is based on correction of the underlying cause of iron loss and replacement of body iron deposits. In megaloblastic anemia, it is useful to distinguish whether folate, vitamin B12, or combined folate and vitamin B12 deficiencies have led to anemia. Therapy is based on replacement. Anemia of chronic diseases can be improved by therapy with recombinant erythropoietin, commonly used in anemia from renal insufficiency. Therapy of warm autoimmune hemolytic anemias is based on corticosteroid therapy. Other therapeutic possibilities include splenectomy and immunosuppressive therapy. Cold autoimmune hemolytic anemias frequently only need cold avoidance. Therapy of thalassemic syndromes is based on red blood cells transfusions and iron chelation. Congenital red cell membrane defects need prophylaxis with folic acid. Splenectomy is frequently required in spherocytosis, less frequently in elliptocytosis. G6PD deficiency usually does not require any therapy, except during acute hemolytic crisis. PK deficiency usually requires folic acid prophylaxis, and splenectomy in selected cases. Iron chelation can be necessary.

Original languageItalian
Pages (from-to)227-234
Number of pages8
JournalOspedale Maggiore
Volume93
Issue number3
Publication statusPublished - 1999

Fingerprint

Anemia
Folic Acid
Splenectomy
Iron
Therapeutics
Autoimmune Hemolytic Anemia
Megaloblastic Anemia
Vitamin B 12 Deficiency
Glucosephosphate Dehydrogenase Deficiency
Erythrocyte Transfusion
Vitamin B 12
Immunosuppressive Agents
Erythropoietin
Renal Insufficiency
Adrenal Cortex Hormones
Chronic Disease
Cell Membrane

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Iurlo, A., Barcellini, W., Barraco, F., & Zanella, A. (1999). Atteggiamento terapeutico nelle anemie. Ospedale Maggiore, 93(3), 227-234.

Atteggiamento terapeutico nelle anemie. / Iurlo, A.; Barcellini, W.; Barraco, F.; Zanella, A.

In: Ospedale Maggiore, Vol. 93, No. 3, 1999, p. 227-234.

Research output: Contribution to journalArticle

Iurlo, A, Barcellini, W, Barraco, F & Zanella, A 1999, 'Atteggiamento terapeutico nelle anemie', Ospedale Maggiore, vol. 93, no. 3, pp. 227-234.
Iurlo, A. ; Barcellini, W. ; Barraco, F. ; Zanella, A. / Atteggiamento terapeutico nelle anemie. In: Ospedale Maggiore. 1999 ; Vol. 93, No. 3. pp. 227-234.
@article{b0f005f034a540daa88da7e562ffc6c3,
title = "Atteggiamento terapeutico nelle anemie",
abstract = "The therapeutic approach in the most common types of anemia is briefly reviewed. Therapy of sideropenic anemia is based on correction of the underlying cause of iron loss and replacement of body iron deposits. In megaloblastic anemia, it is useful to distinguish whether folate, vitamin B12, or combined folate and vitamin B12 deficiencies have led to anemia. Therapy is based on replacement. Anemia of chronic diseases can be improved by therapy with recombinant erythropoietin, commonly used in anemia from renal insufficiency. Therapy of warm autoimmune hemolytic anemias is based on corticosteroid therapy. Other therapeutic possibilities include splenectomy and immunosuppressive therapy. Cold autoimmune hemolytic anemias frequently only need cold avoidance. Therapy of thalassemic syndromes is based on red blood cells transfusions and iron chelation. Congenital red cell membrane defects need prophylaxis with folic acid. Splenectomy is frequently required in spherocytosis, less frequently in elliptocytosis. G6PD deficiency usually does not require any therapy, except during acute hemolytic crisis. PK deficiency usually requires folic acid prophylaxis, and splenectomy in selected cases. Iron chelation can be necessary.",
keywords = "Anemia, Anemia of chronic diseases, Autoimmune hemolytic anemia, Chronic renal failure, Enzymopathies, Megaloblastic anemia, Red cell membrane defects, Sideropenia, Thalassemia",
author = "A. Iurlo and W. Barcellini and F. Barraco and A. Zanella",
year = "1999",
language = "Italian",
volume = "93",
pages = "227--234",
journal = "Ospedale Maggiore",
issn = "0369-7843",
publisher = "Masson Italia Periodici",
number = "3",

}

TY - JOUR

T1 - Atteggiamento terapeutico nelle anemie

AU - Iurlo, A.

AU - Barcellini, W.

AU - Barraco, F.

AU - Zanella, A.

PY - 1999

Y1 - 1999

N2 - The therapeutic approach in the most common types of anemia is briefly reviewed. Therapy of sideropenic anemia is based on correction of the underlying cause of iron loss and replacement of body iron deposits. In megaloblastic anemia, it is useful to distinguish whether folate, vitamin B12, or combined folate and vitamin B12 deficiencies have led to anemia. Therapy is based on replacement. Anemia of chronic diseases can be improved by therapy with recombinant erythropoietin, commonly used in anemia from renal insufficiency. Therapy of warm autoimmune hemolytic anemias is based on corticosteroid therapy. Other therapeutic possibilities include splenectomy and immunosuppressive therapy. Cold autoimmune hemolytic anemias frequently only need cold avoidance. Therapy of thalassemic syndromes is based on red blood cells transfusions and iron chelation. Congenital red cell membrane defects need prophylaxis with folic acid. Splenectomy is frequently required in spherocytosis, less frequently in elliptocytosis. G6PD deficiency usually does not require any therapy, except during acute hemolytic crisis. PK deficiency usually requires folic acid prophylaxis, and splenectomy in selected cases. Iron chelation can be necessary.

AB - The therapeutic approach in the most common types of anemia is briefly reviewed. Therapy of sideropenic anemia is based on correction of the underlying cause of iron loss and replacement of body iron deposits. In megaloblastic anemia, it is useful to distinguish whether folate, vitamin B12, or combined folate and vitamin B12 deficiencies have led to anemia. Therapy is based on replacement. Anemia of chronic diseases can be improved by therapy with recombinant erythropoietin, commonly used in anemia from renal insufficiency. Therapy of warm autoimmune hemolytic anemias is based on corticosteroid therapy. Other therapeutic possibilities include splenectomy and immunosuppressive therapy. Cold autoimmune hemolytic anemias frequently only need cold avoidance. Therapy of thalassemic syndromes is based on red blood cells transfusions and iron chelation. Congenital red cell membrane defects need prophylaxis with folic acid. Splenectomy is frequently required in spherocytosis, less frequently in elliptocytosis. G6PD deficiency usually does not require any therapy, except during acute hemolytic crisis. PK deficiency usually requires folic acid prophylaxis, and splenectomy in selected cases. Iron chelation can be necessary.

KW - Anemia

KW - Anemia of chronic diseases

KW - Autoimmune hemolytic anemia

KW - Chronic renal failure

KW - Enzymopathies

KW - Megaloblastic anemia

KW - Red cell membrane defects

KW - Sideropenia

KW - Thalassemia

UR - http://www.scopus.com/inward/record.url?scp=0032750639&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0032750639&partnerID=8YFLogxK

M3 - Articolo

AN - SCOPUS:0032750639

VL - 93

SP - 227

EP - 234

JO - Ospedale Maggiore

JF - Ospedale Maggiore

SN - 0369-7843

IS - 3

ER -